HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: M700029-JLR200v1 48/8/1735    most recent Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Field, F. J. Articles by Mathur, S. N. Search for Related Content PubMed PubMed Citation Articles by Field, F. J. Articles by Mathur, S. N. Social Bookmarking                      What's this?

Journal of Lipid Research, Vol. 48, 1735-1745, August 2007
Copyright © 2007 by American Society for Biochemistry and Molecular Biology

Ezetimibe interferes with cholesterol trafficking from the plasma membrane to the endoplasmic reticulum in CaCo-2 cells

F. Jeffrey Field¹, Kim Watt and Satya N. Mathur

Department of Internal Medicine, University of Iowa, Iowa City, IA 52242

Published, JLR Papers in Press, May 1, 2007.

¹ To whom correspondence should be addressed. e-mail: f-jeffrey-field{at}uiowa.edu

Niemann-Pick C1-like 1 protein (NPC1L1) is the putative intestinal sterol transporter and the molecular target of ezetimibe, a potent inhibitor of cholesterol absorption. To address the role of NPC1L1 in cholesterol trafficking in intestine, the regulation of cholesterol trafficking by ezetimibe was studied in the human intestinal cell line, CaCo-2. Ezetimibe caused only a modest decrease in the uptake of micellar cholesterol, but markedly prevented its esterification. Cholesterol trafficking from the plasma membrane to the endoplasmic reticulum was profoundly disrupted by ezetimibe without altering the trafficking of cholesterol from the endoplasmic reticulum to the plasma membrane. Cholesterol oxidase-accessible cholesterol at the apical membrane was increased by ezetimibe. Cholesterol synthesis was modestly increased. Although the amount of cholesteryl esters secreted at the basolateral membrane was markedly decreased by ezetimibe, the transport of lipids and the number of lipoprotein particles secreted were not altered. NPC1L1 gene and protein expression were decreased by sterol influx, whereas cholesterol depletion enhanced NPC1L1 gene and protein expression. These results suggest that NPC1L1 plays a role in cholesterol uptake and cholesterol trafficking from the plasma membrane to the endoplasmic reticulum. Interfering with its function will profoundly decrease the amount of cholesterol transported into lymph.

Supplementary key words Niemann-Pick type C1 • Niemann-Pick C1-like 1 • lipoproteins

Abbreviations: ABC, ATP-binding cassette; apoB, apolipoprotein B; BB, brush-border membranes; DMEM, Dulbecco's Modified Eagle's Medium; LDH, lactate dehydrogenase; NBBM, nonbrush-border membranes; NPC1, Niemann-Pick type C1; NPC1L1, Niemann-Pick C1-like 1 protein

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				J. Iqbal and M. M. Hussain Intestinal lipid absorption Am J Physiol Endocrinol Metab, June 1, 2009; 296(6): E1183 - E1194. [Abstract] [Full Text] [PDF]

				F. J. Field, K. Watt, and S. N. Mathur Origins of intestinal ABCA1-mediated HDL-cholesterol J. Lipid Res., December 1, 2008; 49(12): 2605 - 2619. [Abstract] [Full Text] [PDF]

				Z. Ravid, M. Bendayan, E. Delvin, A. T. Sane, M. Elchebly, J. Lafond, M. Lambert, G. Mailhot, and E. Levy Modulation of intestinal cholesterol absorption by high glucose levels: impact on cholesterol transporters, regulatory enzymes, and transcription factors Am J Physiol Gastrointest Liver Physiol, November 1, 2008; 295(5): G873 - G885. [Abstract] [Full Text] [PDF]

				D. Y. Hui, E. D. Labonte, and P. N. Howles Development and Physiological Regulation of Intestinal Lipid Absorption. III. Intestinal transporters and cholesterol absorption Am J Physiol Gastrointest Liver Physiol, April 1, 2008; 294(4): G839 - G843. [Abstract] [Full Text] [PDF]

				A. B. Weinglass, M. G. Kohler, E. O. Nketiah, J. Liu, W. Schmalhofer, A. Thomas, B. Williams, L. Beers, L. Smith, M. Hafey, et al. Madin-Darby Canine Kidney II Cells: A Pharmacologically Validated System for NPC1L1-Mediated Cholesterol Uptake Mol. Pharmacol., April 1, 2008; 73(4): 1072 - 1084. [Abstract] [Full Text] [PDF]